With more than 32 000 cases, gonorrhoea was the second most commonly reported sexually transmitted infection (STI) in Europe in 2010. As data from the ECDC report Gonococcal antimicrobial susceptibility surveillance in Europe 2010 illustrates, gonococci have become more resistant to common agents for treatment and show reduced susceptibility to newer antibiotics. “This indicates the risk that gonorrhoea may become an untreatable disease in the near future”, stresses ECDC Director Marc Sprenger.
Following an invitation from Greek authorities, a team of experts from the ECDC Programme for HIV/AIDS, Sexually Transmitted and Blood-borne infections, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the WHO Regional Office for Europe will visit Greece on 28 and 29 May 2012. The European Union Agency for Fundamental Rights (FRA) will join the mission as observers.
This workshop brought together experts on HIV monitoring and reporting from EU Member States, ECDC, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), the European Commission, UNAIDS, the World Health Organization and the Civil Society Forum.
The second ECDC advisory group meeting will discuss progress and future challenges in reporting and monitoring following the commitment outlined in the Dublin Declaration.